CD247 and neoplasm: Furthermore, related functions or pathways with ssGSEA showed that patients with low-expression CD247 were more likely to have lower immune activity [lower T cell general, Th1 cells, TIL (tumor-infiltrating lymphocytes), checkpoint, cytolytic activity, T cell co-inhibition, and T cell exhaustion scores)] and higher degree of inflammation response [higher DCs (dendritic cell), M2 macrophages, and neutrophils] compared with patients with high-expression CD247 in the three datasets (Figure 8), which was consistent with the results of CIBERSORT analysis (Supplementary Figures 4A, C, E).